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Aims: To use a three-phase process to develop and validate new self-report measures of diabetes-
specific health-related quality of life (HRQOL) for adults with type 1 diabetes. We report on four 
versions of the Type 1 Diabetes and Life (T1DAL) measure for people age 18-25, 26-45, 46-60, 
and over 60 years. 
Methods: We first conducted qualitative interviews to guide measure creation, then piloted the 
draft measures. We evaluated psychometric properties at six T1D Exchange Clinic Network sites 
via completion of T1DAL and validated measures of related constructs. Participants completed the 
T1DAL again in 4-6 weeks. We used psychometric data to reduce each measure to 23-27 items in 
length. Finally, we obtained participant feedback on the final measures. 
Results: The T1DAL-Adult measures demonstrated good internal consistency (α=0.85-0.88) and 
test-retest reliability (r=0.77-0.87). Significant correlations with measures of general quality of 
life, generic and diabetes-specific HRQOL, diabetes burden, self-management, and glycemic 
control demonstrated validity. Factor analyses yielded 4-5 subscales per measure. Participants 
were satisfied with the final measures and reported they took 5-10 minutes to complete. 
Conclusions: The strong psychometric properties of the newly developed self-report T1DAL 
measures for adults with type 1 diabetes make them appropriate for use in clinical research and 
care. 
Keywords: Patient-reported Outcomes, Quality of life, Psychosocial, Assessment
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1. INTRODUCTION 
Health-related quality of life (HRQOL) is a recognized patient-reported outcome defined 
as one’s perception of their own well-being with respect to health status, physical functioning, 
health-related concerns, social and emotional functioning, and treatment satisfaction [1,2]. There 
is growing consensus about the importance of considering HRQOL and other patient-reported 
outcomes as key study outcomes in clinical trials [3], particularly in diabetes [4]. Clinically, the 
American Diabetes Association recommends routine screening and care aimed at improving 
psychosocial outcomes including HRQOL [5,6]. Thus, it is critical to use psychometrically sound 
instruments to assess diabetes-specific HRQOL. 
Researchers conceptualize diabetes-specific HRQOL in various ways, and use many 
different measures to capture this construct (or specific aspects of the construct) [7]. Gaps in the 
availability of validated measures of diabetes-specific HRQOL for adults with type 1 diabetes and 
characteristics of existing measures limit their utility for research and clinical purposes [2,7-9]. 
Reviews of diabetes HRQOL measures [2,7-10] have identified common concerns with the 
conceptual, psychometric, and logistical aspects of existing measures. Conceptually, lack of clarity 
about what comprises diabetes-specific HRQOL has led to the widespread use of the term to 
represent many psychosocial or patient-reported outcome measures, even if they do not assess the 
construct of diabetes-specific HRQOL exactly or in full. For example, several that purport to assess 
HRQOL actually measure related constructs, such as diabetes distress, diabetes self-management 
behaviors/barriers, diet, health status, global well-being, and treatment satisfaction [7]. Fisher and 
colleagues [8] argue that researchers often select measures because others have used them 
previously, even if the measures do not assess HRQOL accurately or precisely. Using measures 
that assess patient-reported outcomes that are associated with but not equivalent to HRQOL 
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confounds HRQOL with other constructs (e.g., physical or emotional functioning, more general 
quality of life) and results in misleading research conclusions. Thus, it is recommended that 
researchers select well-designed and psychometrically sound measures that are contemporary, 
comprehensive, and disease-specific to most precisely measure HRQOL [7,9]. 
Reviews of existing HRQOL measures in diabetes [2,7-10] also identified problems with 
psychometrics and measure development. Commonly noted psychometric concerns include that 
reliability and/or validity data of HRQOL measures were often not reported, or indicated low 
reliability, validity, or range of scores. Construct validity concerns have been raised for measures 
that ask participants to rate their HRQOL with diabetes compared to a hypothetical life without 
diabetes, or that focus on physical symptoms or diabetes treatment burdens without assessing any 
positive experiences related to HRQOL. Moreover, during measure development, content was 
typically developed by professionals without adequate input from people with diabetes [1,11]. 
Many measures blend type 1 and type 2 diabetes, despite differences in disease presentation and 
treatment. Additionally, very few measures take a developmental approach or recognize potential 
differences in people’s experiences with HRQOL at different periods of the lifespan [9], limiting 
the ability to track HRQOL over time or at different points in the lifespan. Total or composite 
scores are often reported, without factor analyses to identify subscales representing conceptually 
distinct aspects of HRQOL. Logistical concerns include measures that lack options to indicate 
when particular aspects of HRQOL are not applicable to the respondent and high response burden 
for measures that are very long or complicated to complete. 
    Two diabetes-specific HRQOL measures have been recently developed that overcome some of 
the limitations of previous diabetes-specific HRQOL measures. The Dawn Impact of Diabetes 
Profile (DIDP) is a brief measure assessing the perceptions of adults (age 18-75) with type 1 or 
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type 2 diabetes about how much diabetes has impacted their quality of life, with strong 
psychometric properties [12]. The DIDP includes one item for each of six or seven dimensions of 
HRQOL: physical health, financial issues, relationships, leisure activities, work or education, 
emotional well-being, and dietary flexibility (optional). The DIDP addresses both positive and 
negative impacts of diabetes, and was designed so that a companion version for family members 
of people with diabetes could be developed. The ViDa1is a 34-item measure of T1D-specific 
HRQOL with strong psychometrics [13]. There are four subscales derived from factor analysis: 
interference in everyday life, self-care, well-being, and disease-related worries.  The ViDal was 
validated on people with T1D age 14-71 years of age. Both the DIDP and ViDal are valuable 
additions to the field of diabetes-specific HRQOL assessment. However, the DIDP is not specific 
to the experiences of people with T1D and is quite brief, making it well-positioned as an HRQOL 
screener but potentially limited in its ability to provide a breadth of clinically useful HRQOL 
information. Neither measure was designed to be developmentally tailored to reflect the unique 
HRQOL issues of distinct life stages (e.g., young adulthood, older adulthood), which may limit 
their precision. 
Although there are measures that assess aspects of diabetes-specific HRQOL for adults 
with type 1 diabetes, the limitations of existing measures indicate a need for new measures that 
add options for HRQOL assessment. Ideally, new HRQOL measures should be brief, clinically 
relevant, psychometrically sound, and developmentally appropriate, and should precisely assess 
T1D-specific HRQOL rather than a related construct. Ultimately, clinicians and researchers need 
to be able to select a well-validated diabetes-specific HRQOL measure that best suits their needs 
[8,10].  Thus, as part of a larger study, which aimed to design and validate a new set of measures 
of diabetes-specific HRQOL for both people with type 1 diabetes across the lifespan and their 
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family members, we report here on  the creation and evaluation of psychometric properties 
(validity, reliability, factor structure) of new diabetes-specific HRQOL measures for adults with 
type 1 diabetes. We previously published psychometric data for “Type 1 Diabetes and Life” 
(T1DAL) measures for children (age 8-11) and adolescents (age 12-17) [14], and for parents of 
youth and partners of adults with T1D [15]. In this paper, we report on the creation of T1DAL 
measures for adults in four age-bands: Young Adult (age 18-25), Adult-1 (age 26-45), Adult-2 
(age 46-60), and Older Adult (age >60). We selected the age-bands based on developmental stages 
[16,17]. It was hypothesized that each T1DAL adult measure would be psychometrically valid 
(i.e., demonstrate construct and criterion validity) and reliable (i.e., demonstrate internal 
consistency and test-retest reliability). An exploratory aim was to identify subscales for each 
measure using factor analysis. 
2. SUBJECTS, MATERIALS, AND METHODS
2.1 Study Design
To create and validate the new T1DAL measures, we followed multi-step measure 
development guidelines [18,19]. The aim of Phase 1 was to draft, pilot, and revise the measures 
based on prior instruments, literature, and qualitative data from adults with type 1 diabetes and 
their partners. The aim of Phase 2 was to test the measures’ psychometrics and factor structure and 
reduce the measures’ length. The aim of Phase 3 was to collect user feedback about the measures 
and make final changes to the number and content of items. Each phase received appropriate 
institutional review board approval. Participants received small monetary incentives for 
participation. Figure 1 illustrates the phases of the study, the number of participants in each phase, 
and the number of items on each version of the measure in each phase. 
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2.2 Recruitment 
Inclusion criteria for all phases were age ≥18 years, type 1 diabetes duration of ≥12 months, 
fluent in written/spoken English, and able to provide informed consent. Exclusion criteria included 
significant comorbid medical, cognitive, or mental health conditions that could interfere with 
ability to participate. In all phases, study staff conducted informed consent processes including 
introduction of the study to potential participants and evaluation of understanding prior to 
obtaining written consent. Table 1 summarizes participants’ demographic and clinical 
characteristics for each phase.
Phase 1 
Participants were recruited from diabetes clinics at Indiana University School of Medicine. 
Research staff identified potentially eligible participants based on review of diabetes clinic 
schedules. Study staff sent informational letters to potentially eligible people and followed up by 
telephone, then conducted informed consent procedures in person at either a medical appointment 
or separate appointment. To enroll a sample of an adequate size for qualitative research, which 
would allow us to include people with a range of experiences and reach thematic saturation, we 
had recruitment targets of 6-10 participants per age-band (i.e., 24-40 total for the adult age-bands) 
[20]. We mailed letters to 233 potentially eligible adults. Study staff contacted 38 people who met 
eligibility criteria, and 28 (74%) consented and completed the interview. Once the recruitment 
targets were met, we did not continue to contact others who received letters. 
After developing first drafts of the T1DAL measures for each age range, staff recruited 11 
new adult participants (2-3 per age-band) to pilot and provide feedback about these newly drafted 
measures. This sample size is in the recommended range for pre-testing items on a newly 
developed measure [18,20].
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Phase 2 
Participants were recruited from six diabetes centers within the T1D Exchange Clinic 
Network (investigators and staff at each site listed in Appendix 4). Sites were selected based on 
clinic size, geographic diversity, and history of successful engagement in multisite research of this 
nature. All age-bands were recruited from adult sites in Colorado, Michigan, and New York. 
Because young adults receive diabetes care in either pediatric or adult healthcare settings [21], 
participants age 18-25 were also recruited from pediatric sites in California, Colorado, and 
Tennessee. Research staff at each site reviewed schedules to identify potentially eligible 
participants from the clinic. All clinic patients were potentially eligible for this study; while staff 
prioritized recruiting participants, who were previously enrolled in the T1D Exchange Clinic 
Registry to facilitate access to existing demographic data, enrollment in the current study was not 
limited to prior registry participation. Sites sent informational letters and/or met potential 
participants at clinic visits to introduce the study and conduct informed consent procedures. Given 
the goal for the measures to ultimately be 20-30 items in length, our recruitment targets were 200-
300 participants per age-band [18]. In total, 962 people enrolled: Age 18-25, n=252; Age 26-45, 
n=274; Age 46-60, n=250; Age >60, n=164.
Phase 3 
The investigators recruited a new sample through Twitter, to conduct a final review of the 
measures. The recruitment target was 2-3 new participants per age-band (i.e., 8-12 across the adult 
age-bands); this small sample was adequate for the purpose of obtaining a last opportunity for 
feedback from people who were unfamiliar with the measures [20]. Interested people contacted 
the study team by direct message, email, or telephone. Staff followed-up by telephone to describe 
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the study, determine eligibility, and obtain informed consent. Nine people who contacted the study 
team were eligible and participated. 
2.3 Procedures
Phase 1
Based on literature review and clinical observations, the investigators created a list of 
HRQOL topics to potentially assess in the measures. Staff used semi-structured scripts to conduct 
individual interviews and/or small focus groups about these topics (excerpts from scripts in 
Appendix 1). Interview questions asked participants to discuss several aspects of living with type 
1 diabetes (e.g., interpersonal interactions, food and activity, thoughts and feelings related to type 
1 diabetes, financial issues) and any other topics they felt were important. Staff were trained to ask 
open-ended questions and use prompts/probes to clarify responses. The interviews were audio-
recorded and professionally transcribed. Participants also reported on their demographics, and staff 
conducted medical chart reviews to extract clinical data (e.g., date of diagnosis, most recent 
HbA1c). 
Following thematic qualitative analysis of the interview transcripts, the study team then 
drafted the T1DAL measures with items written to capture themes based on the qualitative 
interviews, diabetes literature, and clinical experience. The structure and format were based on the 
MY-Q measure of HRQOL [22]. Behavioral and medical expert collaborators on the study team 
reviewed the measures and gave feedback. A new sample of participants piloted the measures, and 
staff conducted structured cognitive debriefing [23] (Appendix 2) to obtain feedback about: 
items/words that were confusing, difficult or uncomfortable to answer, repetitive, or unimportant, 
how hard or easy it was to answer each item, their interpretation of specific words/phrases, and 
suggestions for clarification/improvement. We also sought participant comments about their 
Downloaded for Anonymous User (n/a) at Henry Ford Hospital / Henry Ford Health System (CS North America) from ClinicalKey.com by Elsevier on December 16, 2020.
For personal use only. No other uses without permission. Copyright ©2020. Elsevier Inc. All rights reserved.
Type 1 Diabetes Health-Related Quality of Life
10
feelings about completing this questionnaire in clinic and any other topics related to living with 
type 1 diabetes that they felt should be included. Interviews were audio-recorded and 
professionally transcribed, and interviewers summarized the feedback. The investigators then 
modified item wording and removed problematic items based on this feedback. 
Phase 2
Participation included completing questionnaires on two occasions on a secure web-based 
portal, either at the clinic visit or at home via emailed link. Paper questionnaires were available 
upon request. At enrollment, participants completed the age-appropriate T1DAL measure and 
validated measures of related constructs to evaluate construct validity at baseline (outlined below). 
At follow-up (4-6 weeks later), participants completed the T1DAL measure only to examine test-
retest reliability. Participants also granted study staff access to clinical and demographic data from 
medical charts and the Clinic Registry Study. 
Phase 3
A new sample of nine participants completed the age-appropriate measure (PDF sent via 
email) and timed themselves while answering the measure. Staff then completed a cognitive 
interview by telephone using a similar script as in Phase 1 to obtain participant input about the 
measure’s clarity, appropriateness, and repetitiveness. Interviews were audio-recorded and 
professionally transcribed, and interviewers summarized the participant comments. Study team 
members also reviewed and commented. The primary investigators finalized the measures based 
on participant and expert feedback. 
2.3 Measures
2.3.a. T1DAL Measure
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The number of items on each original version of the T1DAL in the validation study was 
52 (age 18-25), 54 (age 26-45), 48 (age 46-60), and 49 (age >60). Instructions directed respondents 
to answer each item on a 5-point Likert scale (‘Completely Disagree’ to ‘Completely Agree’) based 
on their experience in the past 4 weeks. Items were presented in conceptual categories, such as 
“Diabetes at Work” and “Diabetes and How I Feel” and included an option to indicate items that 
were not applicable. Positively-worded items were scored 0=0, 1=25, 2=50, 3=75, or 4=100 and 
negatively-worded items were reverse-scored. Subscale and total scores were calculated by 
computing the mean and multiplying by 25 to convert to the 0-100 scale. Higher scores indicated 
better HRQOL. To avoid over-interpreting individual items, scores were not calculated if >10% 
of items were missing (>1 missing item for subscale score, >3 missing items for total score). 
2.3.b. Construct Validity Measures
To assess general quality of life, the Satisfaction with Life Scale (SWLS) [24] prompted 
participants to rate their agreement with five judgements about their life from 1 (‘Strongly 
Disagree’) to 7 (‘Strongly Agree’). The α range across age-bands in this sample was 0.90-0.93. 
To assess HRQOL, all participants completed the Pediatric Quality of Life Inventory 
(PedsQL1) Generic Core Scales Version 4.0 (generic HRQOL, 23 items), which has versions for 
adults aged 18-25 and over age 26 [25,26]. Participants between ages 18-45 also completed the 
Diabetes Module Version 3.2 (diabetes-specific HRQOL, 33 items) using the version validated for 
their age (there is no version for people over age 45) [25,27,28]. On each measure, they rated how 
much each item was a problem. In this sample, the α ranges were 0.92-0.94 (Generic) and 0.91-
0.93 (Diabetes). 
1 Despite the PedsQL measures having the term Pediatric in the title, their validation samples have since been 
extended to include adults. In-text citations refer to the adult validation publications. 
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Participants also completed the Short Form Health Survey, Version 2 (SF-12) [29], a 12-
item assessment of physical functioning and symptoms, general health, and mental health 
symptoms. The α range in this sample was 0.33-0.45. We used the Mental Health Composite Score 
(MCS) in validity analyses, as it is most conceptually related to HRQOL. 
To assess diabetes-related burdens, participants completed the Problem Areas in Diabetes 
scale (PAID) [30]. On this 20-item measure, respondents rate how much of a burden each item is 
(5-point scale: ‘Not A Problem’ to ‘Serious Problem’). In this sample, the α range was 0.94-0.96. 
2.3.c. Criterion Validity Measures
To assess adherence, participants completed the Self-Care Inventory-Revised [31], which 
assesses completion of diabetes management behaviors (5-point scale: ‘Never Do It’ to ‘Always 
Do This As Recommended Without Fail’). The α range in this sample was 0.74-0.85. To assess 
glycemic control, the HbA1c value closest to the date of study participation was extracted from 
each participant’s medical record. 
2.4 Data Analysis
Phase 1
We conducted hybrid thematic analysis of the interview/focus group transcripts [32], 
following qualitative research methods guidelines [20,33] using NVIVO software (Version 11). 
Three behavioral scientists with expertise in diabetes and three research coordinators reviewed 
transcripts, identified common concepts, and created a codebook with operational definitions of 
these concepts for each code. As the team applied the codes to the transcripts, we discussed any 
additional concepts that we observed in the transcripts and added definitions to the codebook. This 
iterative process continued until there were no new codes identified. We double-coded 25% of 
transcripts and resolved any disagreements. 
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Phase 2
We conducted separate analyses by age-band. Table 1 presents the number of participants 
included in analyses (those with calculable T1DAL scores) in each age-band. First, we conducted 
exploratory factor analyses with all T1DAL items, using squared multiple correlations as prior 
communality estimates. Because there were no a priori hypothesized factors for each version of 
the newly developed T1DAL measures, exploratory factor analysis was more appropriate than 
confirmatory methods. We used maximum likelihood and promax (oblique) rotation to extract 
factors. We examined scree plots, proportion of variance explained, and clinical interpretability to 
decide on the number of meaningful factors for each age band. We inspected item properties to 
shorten each age-band’s measure to 20-25 items, based on the following decision rules: no change 
in α if item dropped, ≥85% response rate, no ceiling or floor effect, and significant loading (≥0.30) 
on ≥1 factor. We also dropped items that assessed other constructs (e.g., self-management), were 
redundant, or received negative cognitive debriefing feedback. For any items loading on >1 factor, 
we considered each factor loading and conceptual fit. Each factor required ≥3 variables. In some 
cases, we retained individual items that did not load onto any factor but were deemed by the 
investigator team to be clinically meaningful and important to include on the measure. To evaluate 
reliability (internal consistency) we calculated Cronbach’s α, and to evaluate validity and test-
retest reliability, we calculated Pearson’s correlations with other measures or across both 
timepoints.
Phase 3
No formal analyses were conducted for Phase 3 interview data, as the comments were brief 
and interpretable by visual review alone. Study team members reviewed the feedback from 
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participants and discussed whether any additional changes to the measures were indicated based 
on the feedback. 
3. RESULTS
Phase 1
Qualitative analysis identified many themes related to diabetes-specific HRQOL, including 
feelings about diabetes, interpersonal relationships, and barriers to/facilitators of managing 
diabetes in everyday activities, reported elsewhere [34-36]. Feedback from participants during 
cognitive debriefing guided changes to the measures to increase clarity (e.g., cutting confusing 
items, adding instructions for clarification) and reduce redundancy between items. 
Phase 2 
For the Young Adult version (age 18-25), we included data from 252 participants in the 
factor analysis. The total score α was 0.92 (α with deleted variable, range = 0.92-0.92). We retained 
27 items for the final T1DAL-Young Adult questionnaire, total score M=73.0±14.0, α=0.88 (α 
with deleted variable, range = 0.87-0.88), Fleisch-Kincaid=8.6. The final four factors were 
Emotional Experiences and Daily Activities (12 items), Handling Diabetes Well (4 items), Peer 
Relationships (5 items), and Healthcare Experiences (4 items). We retained two items that did not 
load on any factor, as they addressed a clinically important topic (family planning) that was not 
otherwise captured in the measure. 
For the Adult-1 version (age 26-45), we used data from 243 participants. The total score α 
was 0.91 (α with deleted variable, range = 0.90-0.91). We retained 27 items for the final T1DAL-
Adult-1 questionnaire, total score M=63.0±12.8, α=0.85 (α with deleted variable, range = 0.83-
0.85), Fleisch-Kincaid=8.6. The final five factors were Emotional Experiences and Daily 
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Activities (12 items), Peer Relationships (4 items), Family Relationships (3 items), Financial 
Considerations (3 items), and Healthcare Experiences (3 items). Similar to the Young Adult 
version, we retained two items about family planning that did not load on any factor. 
For the Adult-2 version (age 46-60), we included data from 190 participants. The total 
score α was 0.90 (α with deleted variable, range = 0.90-0.90). We retained 25 items for the final 
T1DAL-Adult-2 questionnaire, total score M=62.0±15.1, α=0.87 (α with deleted variable, range = 
0.85-0.87), Fleisch-Kincaid=7.8. The final five factors were Emotional Experiences and Daily 
Activities (7 items), Support from Others (4 items), Social Isolation (4 items), Financial 
Considerations (3 items), and Handling Diabetes Well (5 items). Similar to the Young Adult and 
Adult-1 versions, we retained two items that were clinically important (parenting one’s own 
children, concerns regarding complications) but did not load on any factor. 
For the Older Adult version (age >60), we included data from 160 participants. The total 
score α was 0.89 (α with deleted variable, range = 0.88-0.89). We retained 23 items for the final 
T1DAL-Older Adult questionnaire, total score M=61.7±15.5, α=0.86 (α with deleted variable, 
range = 0.84-0.86), Fleisch-Kincaid=8.5. The final four factors were Emotional Experiences and 
Social Isolation (12 items), Support from Others (3 items), Financial Considerations (3 items), and 
Handling Diabetes Well (5 items). 
Table 1 presents the descriptive statistics for each validity measure. Tables 2 and 3 present 
the reliability and validity data for the total and subscale scores for each T1DAL measure. The 
total scores all demonstrated good internal consistency (α>0.80) and most subscales also 
demonstrated fair-good internal consistency (α>0.60). All T1DAL subscales and total scores had 
significant (p <0.0001) test-retest reliability correlations. All total scores and most subscale scores 
also demonstrated construct and criterion validity, with significant (at least p <0.05) correlations 
Downloaded for Anonymous User (n/a) at Henry Ford Hospital / Henry Ford Health System (CS North America) from ClinicalKey.com by Elsevier on December 16, 2020.
For personal use only. No other uses without permission. Copyright ©2020. Elsevier Inc. All rights reserved.
Type 1 Diabetes Health-Related Quality of Life
16
with the validity measures in the expected directions. Appendix 3 provides example items for each 
measure. Appendix 4 provides example items that were deleted from each measure, with the 
reasons for deletion. 
Phase 3
Participants reported that the measures were understandable, comfortable to answer, and 
relevant to their experiences with type 1 diabetes. They estimated the measures took less than 10 
minutes to complete. 
4. DISCUSSION 
The self-report T1DAL measures, assessing age-appropriate diabetes-specific HRQOL in 
adults with type 1 diabetes, are psychometrically sound and appropriate for use in clinical care and 
research. Based on input gathered from adults with type 1 diabetes, the measures were developed 
and tested using rigorous qualitative and quantitative methods. This level of rigor in measure 
development and detailed psychometric data represents a significant advance beyond what has 
been reported for existing measures of HRQOL in adults with T1D. The T1DAL measures were 
designed to be brief, clinically relevant, and to capture real life experiences relevant to clinical 
trials and practice settings.  The T1DAL total scores showed that adults in each age-band reported 
moderate diabetes-specific HRQOL, suggesting there is potential for HRQOL to improve with 
intervention [37,38]. 
Psychometric properties of the T1DAL measures were very strong. Each total score 
exhibited consistent validity and reliability. The significant associations with construct validity 
measures (i.e., other measures of quality of life and diabetes distress) demonstrate that the new 
T1DAL measures for adults provide accurate assessments of the patient-reported outcome 
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constructs that are part of HRQOL. The consistent associations between total scores and criterion 
validity measures (i.e., self-management behaviors and glycemic outcomes) further support the 
accuracy of the T1DAL measures in relation to key diabetes outcomes. The factors identified in 
factor analysis also had significant construct validity and test-retest reliability, supporting the 
psychometric properties of the subscales. The relatively low internal consistency of some subscales 
was due to small number of items per factor, which was intentional to reduce redundancy between 
items and maintain brevity. Mixed associations with the criterion validity measures suggest that a 
few subscales may not be directly related to self-management or glycemic outcomes, but this does 
not detract from their importance or contribution in relation to assessing and understanding overall 
HRQOL. 
The rigorous multi-step development and validation process for the new T1DAL-Adult 
measures [18], and the comprehensive reporting of validity and reliability in these measures, 
address many of the gaps and concerns in existing HRQOL instruments [1,2,7-10]. Specifically, 
we followed guidelines for involving the target population in developing, piloting, and revising 
the measures, which has not been done consistently with previous HRQOL measures. Given 
concerns about the use of measures capturing other factors that are related but not precisely 
HRQOL, we made concerted efforts to ensure the T1DAL measures aligned with accepted, multi-
faceted conceptualizations of HRQOL [7,9]. During the item generation and refinement process, 
and during the questionnaire-shortening step using validation data, we carefully selected items that 
assessed HRQOL specifically, rather than related constructs such as self-management or general 
quality of life. Additionally, we emphasized a well-rounded conceptualization of HRQOL, 
including both positive and negative aspects of living with type 1 diabetes. Finally, we reported 
detailed results regarding reliability, validity, and factor analyses, to provide comprehensive 
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psychometric properties about the new measures. Thus, the new T1DAL-Adult measures add a 
new option that is distinct from existing measures of HRQOL and add value in their theory-based 
conceptualization, stepwise development, rigorous validation, and detailed reporting of 
psychometric data.  
Together with the validated T1DAL measures for children and adolescents [14], the adult 
T1DAL measures can be used to assess diabetes-specific HRQOL across the lifespan. The 
investigators created and evaluated each age-band’s measure separately to generate 
developmentally specific items and subscales. We began with qualitative data from adults with 
type 1 diabetes in each age-band to ensure the final measures represented the specific HRQOL-
related experiences of each life stage [9].  Using the same scoring approach for each measure 
allows users to not only compare scores within each age-band, but to assess HRQOL longitudinally 
as people move though different age-bands. 
4.1 Limitations and Considerations. 
Limitations of this research should be considered. As with all research, participant 
characteristics may limit the generalizability of the results. Because we did not obtain consent from 
people who declined to participate, we were unable to determine whether or in what ways the 
enrolled sample was biased. Additionally, we did not collect data on complications, which may be 
related to HRQOL, so it is not possible to determine how similar this sample is to the population 
in this regard. We conducted the Phase 1 qualitative interviews that informed the T1DAL 
assessments at an academic medical center in an urban area in the Midwestern United States. The 
characteristics and experiences of patients at this center may differ from people in other locations. 
Across the different study phases, samples were largely non-Hispanic White (especially in the 
older age-bands) and some had relatively high use of insulin pumps. However, the sample’s 
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recruitment of participants from across the U.S. in the validation phase and the consistency of the 
results across age-bands and with previous research reduce these concerns. Additionally, 
psychometric validity patterns of the T1DAL-Adult measures (Young Adult, Adult-1, Adult-2, 
and Older Adults) were similar to the psychometric results previously published for the T1DAL-
Child and Adolescent versions, which had more racial/ethnic diversity [14], further reducing 
concerns about this limitation. Future research examining the psychometrics and functionality of 
the measures for racially/ethnically and socio-economically diverse people with diabetes is critical. 
The construct validity should be considered in relation to the measures used for 
comparisons. We selected the PedsQL measure for diabetes-specific HRQOL, largely to ensure 
consistency in methods used across the lifespan. While the PedsQL measures were originally 
developed for youth and later validated in adults [26-28], limitations include having published 
psychometrics only up to age 45 for the Diabetes Module. Using a different measure designed 
specifically for older adults may have generated different results. For general HRQOL, PedsQL 
Generic Core Scales psychometric data are published up to age 25 (although there is a version 
available for people age 26 and older [25]). To address this, we supplemented with the Mental 
Health Composite of the SF-12, another measure of HRQOL. The construct validity results with 
the SF-12 measure should also be considered with caution given its low α, however its inclusion 
is supported both by its established psychometric strength and the overall consistent pattern of 
T1DAL correlations with the SF-12 and other construct validity measures. These challenges with 
the construct validity measures we used for HRQOL further underline the gaps in existing 
measures of this important construct. They also highlight the need for a new, well-constructed and 
well-validated measure of HRQOL with developmentally appropriate versions across the lifespan.
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One gap in constructs assessed in T1DAL is the use of diabetes devices and technologies 
in relation to HRQOL. As these technologies are advancing rapidly, we elected not to include 
content that could quickly become outdated. Other relevant measures (e.g., Diabetes Technology 
Questionnaire for continuous glucose monitoring [39]; INSPIRE measures for automated insulin 
delivery [40]) were designed specifically to address issues related to about diabetes technologies 
and may be used with the T1DAL measures. Additionally, conducting sensitivity analyses were 
beyond the scope of this study, so we cannot comment on how scores change in relation to shifts 
in clinical outcomes or care. Future research evaluating the T1DAL measures’ sensitivity to 
change and feasibility in practice settings will help inform the utility and implementation of the 
measures in clinical care and clinical trials.
4.2 Conclusion
The newly developed T1DAL measures for adults with type 1 diabetes comprise a 
rigorously constructed and tested set of questionnaires that address many concerns of previous 
HRQOL assessment. The brevity and clinical relevance of the T1DAL measures for adults make 
them suitable for use to assess diabetes-specific HRQOL, a key patient-reported outcome, in 
clinical practice and research. An important addition compared to other measures is the inclusion 
of both negative and positive aspects of living with diabetes, which provides a fuller assessment 
of this broad construct. Together with versions for children and adolescents with type 1 diabetes 
[14], T1DAL offers a new option for HRQOL measurement across the lifespan, and the 
developmentally tailored content with consistent scoring across age-bands permits longitudinal 
measurement. With our rigorous methodological approaches that adhere to guidelines for measure 
development and validation [18], as well as our strong psychometric data, the T1DAL-Adult 
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measures represent an important advance in the field that fills the gaps left by previous research, 
and can be used to improve patient care and clinical research. 
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Figure 1. Flowchart of measure development and validation phases. 
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Table 1. Participant characteristics by study phase. 
Phase 1 Phase 2 Phase 3
Clinical and Demographic Qualitative Debriefing 18-25 26-45 46-60 >60 Debriefing
N° 28 11 252 243 190 160 9
Age, M±SD, years 42.8±15.9 39.8±17.1 21.4±2.3 35.1±6.1 53.8±4.1 67.5±5.3 43.2±19.3
Duration of T1D, M±SD, years 10.8±5.6 18.0±10.1 30.1±14.1 36.6±16.2
Gender, % female 54% 64% 49% 54% 56% 48% 89%
Race/Ethnicity, % non-
Hispanic White

















Insulin regimen, % pump 61% 73% 43% 53% 73% 63% 89%
Validation Measures, M (SD)
PedsQL Diabetes 65.2±14.2 63.4±11.5
PedsQL Generic 79.9±15.6 74.0±15.9 74.6±14.6 71.3±17.0
SF-12 – PCS 53.0±6.3 50.6±8.0 49.9±8.3 46.6±9.8
SF-12 – MCS 44.1±11.1 41.9±10.3 46.7±9.1 47.4±8.8
SWLS 23.9±6.8 23.5±7.2 24.4±7.3 24.4±7.6
PAID 39.5±16.8 39.6±13.6 35.5±14.3 34.2±12.4
SCI-R 3.4±0.6 3.3±0.6 3.6±0.5 3.8±0.5
Notes: °n with calculable HRQOL scores *HbA1c values available for 27 participants in Phase 1: Qualitative. HbA1c = Hemoglobin 
A1c. PedsQL = Pediatric Quality of Life Inventory. SWLS = Satisfaction with Life Scale. PAID = Problem Areas in Diabetes scale. 
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SF-12 = Short Form Health Survey 12, Version 2; PCS = Physical Health Composite Score, MCS = Mental Health Composite Score. 
SCI-R = Self-Care Inventory Revised. 
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Table 2. T1DAL total and subscale scores and reliability estimates. 







18 -25 Total 61.7±15.0 0.88 0.82*
Emotional Experiences & Daily Activities 45.6±20.5 0.86 0.81*
Handling Diabetes Well 70.2±21.1 0.79 0.68*
Peer Relationships 76.2±19.1 0.68 0.61*
Healthcare Experiences 82.5±16.5 0.70 0.56*
26-45 Total 63.9±12.5 0.85 0.85*
Emotional Experiences & Daily Activities 51.0±17.1 0.83 0.82*
Family Relationships 82.5±20.4 0.57 0.71*
Peer Relationships 81.7±17.5 0.63 0.71*
Healthcare Experiences 86.5±18.9 0.83 0.49*
Financial Considerations 46.1±27.5 0.60 0.76*
46-60 Total 61.4±15.3 0.87 0.87*
Emotional Experiences & Daily Activities 42.8±21.8 0.79 0.71*
Financial Considerations 58.0±26.1 0.69 0.74*
Handling Diabetes Well 74.2±17.9 0.66 0.69*
Support from Others 77.4±21.3 0.70 0.60*
Social Isolation 56.4±24.2 0.70 0.74*
>60 Total 62.7±15.5 0.86 0.80*
Emotional Experiences & Social Isolation 50.3±20.1 0.84 0.73*
Handling Diabetes Well 77.4±17.7 0.68 0.67*
Financial Considerations 65.2±27.3 0.68 0.79*
Support from Others 81.0±18.7 0.48 0.45*
Note: °Standardized Cronbach’s alpha *p<0.0001
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18-25 Total 0.71** 0.65** 0.50** -0.70** 0.48** 0.43** -0.23**
Emotional Experiences & Daily Activities 0.73** 0.62** 0.42** -0.70** 0.45** 0.35** -0.17*
Handling Diabetes Well 0.56** 0.53** 0.49** -0.58** 0.44** 0.52** -0.33**
Peer Relationships 0.33** 0.29** 0.21** -0.30** 0.19** 0.26** -0.19*
Healthcare Experiences 0.23** 0.28** 0.24** -0.26** 0.24** 0.26** 0.01
26-45 Total 0.73** 0.67** 0.54** -0.73** 0.59** 0.28** -0.30**
Emotional Experiences & Daily Activities 0.69** 0.63** 0.48** -0.72** 0.56** 0.24** -0.20*
Family Relationships 0.46** 0.45** 0.38** -0.42** 0.36** 0.20** -0.30**
Peer Relationships 0.33** 0.23** 0.27** -0.27** 0.33** 0.15* -0.15
Healthcare Experiences 0.32** 0.28** 0.21** -0.32** 0.15* 0.15* -0.23**
Financial Considerations 0.34** 0.35** 0.27** -0.34** 0.27** 0.10 -0.06
46-60 Total 0.65** 0.52** -0.73** 0.52** 0.19* -0.35**
Emotional Experiences & Daily Activities 0.53** 0.40** -0.69** 0.48** 0.11 -0.20**
Financial Considerations 0.39** 0.42** -0.63** 0.42** 0.23* -0.26**
Handling Diabetes Well 0.40** 0.38** -0.51** 0.44** 0.35** -0.40**
Support from Others 0.23** 0.25** -0.29** 0.23** 0.09 -0.28**
Social Isolation 0.50** 0.36** -0.49** 0.41** 0.05 -0.21**
>60 Total 0.61** 0.57** -0.75** 0.49** 0.19* -0.21*
Emotional Experiences & Social Isolation 0.62** 0.50** -0.75** 0.47** 0.11 -0.18*
Handling Diabetes Well 0.39** 0.42** -0.63** 0.42** 0.23** -0.26**
Financial Considerations 0.24** 0.30** -0.25** 0.20* 0.08 -0.08
Support from Others 0.31** 0.37** -0.28** 0.25** 0.23** -0.05
Notes: *p<.05, **p<.01. PedsQL = Pediatric Quality of Life Inventory. SWLS = Satisfaction with Life Scale. PAID = Problem Areas 
in Diabetes scale. SF-12 MCS = Short Form Health Survey 12, Version 2, Mental Health Composite Score. SCI-R= Self-Care 
Inventory-Revised. HbA1c = Hemoglobin A1c.  
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